Invention Grant
US09255136B2 Inhibiting peptides derived from TREM-like transcript 1 (TLT-1) and uses thereof
有权
抑制衍生自TREM样转录物1（TLT-1）的肽及其用途
- Patent Title: Inhibiting peptides derived from TREM-like transcript 1 (TLT-1) and uses thereof
- Patent Title (中): 抑制衍生自TREM样转录物1（TLT-1）的肽及其用途
-
Application No.: US13639374Application Date: 2011-04-08
-
Publication No.: US09255136B2Publication Date: 2016-02-09
- Inventor: Sebastien Gibot , Marc Derive
- Applicant: Sebastien Gibot , Marc Derive
- Applicant Address: FR Paris FR Nancy
- Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM),Universite de Lorraine
- Current Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM),Universite de Lorraine
- Current Assignee Address: FR Paris FR Nancy
- Agency: Whitham Curtis Christofferson & Cook, PC
- Priority: EP10305364 20100408
- International Application: PCT/EP2011/055519 WO 20110408
- International Announcement: WO2011/124685 WO 20111013
- Main IPC: A61K38/08
- IPC: A61K38/08 ; C12N15/12 ; C12N15/63 ; A61K31/7088 ; A61P29/00 ; C07K7/06 ; C07K7/08 ; A61K38/10 ; C07K14/705 ; A61K38/00
Abstract:
Polypeptide The present invention relates to polypeptides fragments derived from the protein TLT-1 have been isolated and are useful in pharmaceutical preparations used for the treatment of inflammatory conditions such as sepsis.
Public/Granted literature
- US20130029921A1 INHIBITING PEPTIDES DERIVED FROM TREM-LIKE TRANSCRIPT 1 (TLT-1) AND USES THEREOF Public/Granted day:2013-01-31
Information query
IPC分类:
